Danda Trouve Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$51K Sell
593
-284
-32% -$25.4K 0.09% 40
2022
Q2
$80K Hold
877
0.12% 34
2022
Q1
$72K Hold
877
0.09% 42
2021
Q4
$67K Hold
877
0.08% 58
2021
Q3
$66K Hold
877
0.08% 58
2021
Q2
$68K Sell
877
-42
-5% -$3.12K 0.08% 54
2021
Q1
$68K Sell
919
-105
-10% -$7.75K 0.08% 53
2020
Q4
$80K Hold
1,024
0.1% 54
2020
Q3
$81K Sell
1,024
-786
-43% -$61.6K 0.11% 47
2020
Q2
$134K Hold
1,810
0.2% 37
2020
Q1
$133K Buy
1,810
+105
+6% +$8.25K 0.28% 31
2019
Q4
$148K Buy
+1,705
New +$140K 0.21% 37

Other funds holding MRK

Danda Trouve Investment Management's MRK Position: Q3 2022 in Review

Danda Trouve Investment Management reduced its Merck (MRK) stake by 32% in Q3 2022, selling an estimated $25.4K and leaving 593 shares worth $51K. The position accounts for 0.09% of the portfolio, ranked #40.

Danda Trouve Investment Management first reported a position in MRK in Q4 2019 and has held it in 12 quarters since. The position peaked at $148K in Q4 2019. 2,989 funds tracked by Wall St. Rank hold MRK as of Q3 2022.

  • Danda Trouve Investment Management held 593 shares of Merck worth $51K as of Q3 2022.
  • Danda Trouve Investment Management sold 284 Merck shares in Q3 2022, an estimated $25.4K.
  • Merck made up 0.09% of Danda Trouve Investment Management's portfolio in Q3 2022, its #40 holding.
  • Danda Trouve Investment Management first reported a position in Merck in Q4 2019 and has held it in 12 quarters since.
  • Danda Trouve Investment Management's Merck position peaked at $148K in Q4 2019.
  • 2,989 funds tracked by Wall St. Rank held Merck as of Q3 2022.

Based on Danda Trouve Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.